• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名抗双链DNA阴性狼疮性肾炎年轻患者在无C1酯酶抑制剂缺乏情况下的血管性水肿

Angioedema in the Absence of C1 Esterase Inhibitor Deficiency in a Young Patient With Anti-dsDNA Negative Lupus Nephritis.

作者信息

Nadeem Ifrah, Khan Dawlat, Huang Jiannan, Aslam Sadia, Nadeem Anum, Khan Wahab J

机构信息

Internal Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, USA.

Internal Medicine, Avera McKennan Hospital and University Health Center, Sioux Falls, USA.

出版信息

Cureus. 2023 May 17;15(5):e39141. doi: 10.7759/cureus.39141. eCollection 2023 May.

DOI:10.7759/cureus.39141
PMID:37332411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10275392/
Abstract

Hereditary angioedema (HAE) is an autosomal dominant condition marked by a lack of functioning C1 esterase inhibitor (C1-INH). In contrast, acquired angioedema (AAE) due to a deficiency of C1 esterase inhibitor (AAE-C1-INH) may be the manifestation of an underlying lymphoproliferative, neoplastic, or autoimmune condition. Both are potentially fatal. The C1q protein is normal in HAE but low in AAE. A third mechanism has been reported to cause angioedema, especially in systemic lupus erythematosus (SLE) patients. AAE, which happens in association with SLE, may respond well to steroids. Here we present a case of AAE in a young female with SLE that led to upper airway compromise, requiring endotracheal intubation. Early detection and treatment of such cases can lead to an outstanding prognosis by preventing airway compromise and anoxic brain injury. Even though it is a condition of either very young or middle-aged patients, practitioners must be aware of this uncommon disease linked with SLE in adolescents and young adults.

摘要

遗传性血管性水肿(HAE)是一种常染色体显性疾病,其特征是缺乏具有功能的C1酯酶抑制剂(C1-INH)。相比之下,由于C1酯酶抑制剂缺乏导致的获得性血管性水肿(AAE-C1-INH)可能是潜在的淋巴增生性、肿瘤性或自身免疫性疾病的表现。两者都有潜在的致命性。C1q蛋白在HAE中正常,但在AAE中较低。据报道,还有第三种机制可导致血管性水肿,尤其是在系统性红斑狼疮(SLE)患者中。与SLE相关的AAE可能对类固醇治疗反应良好。在此,我们报告一例年轻女性SLE患者发生AAE,导致上呼吸道梗阻,需要进行气管插管。早期发现并治疗此类病例,通过预防气道梗阻和缺氧性脑损伤,可带来良好的预后。尽管这是一种多见于非常年轻或中年患者的疾病,但从业者必须了解这种与青少年和年轻成人SLE相关的罕见疾病。

相似文献

1
Angioedema in the Absence of C1 Esterase Inhibitor Deficiency in a Young Patient With Anti-dsDNA Negative Lupus Nephritis.一名抗双链DNA阴性狼疮性肾炎年轻患者在无C1酯酶抑制剂缺乏情况下的血管性水肿
Cureus. 2023 May 17;15(5):e39141. doi: 10.7759/cureus.39141. eCollection 2023 May.
2
[Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].[通过缓激肽介导的血管性水肿获得性C1酯酶抑制剂缺乏症:4例]
Ann Dermatol Venereol. 2018 Oct;145(10):598-602. doi: 10.1016/j.annder.2018.02.012. Epub 2018 Apr 17.
3
Acquired angioedema in B cell lymphoproliferative disease: A retrospective case series.B 细胞淋巴增殖性疾病相关性获得性血管性水肿:一项回顾性病例系列研究。
Clin Exp Immunol. 2021 Dec;206(3):378-383. doi: 10.1111/cei.13667. Epub 2021 Oct 11.
4
Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.特发性非组胺性获得性血管性水肿与遗传性血管性水肿。
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1205-1208. doi: 10.1016/j.jaip.2018.04.018. Epub 2018 Apr 30.
5
Acquired Angioedema due to C1 Inhibitor Deficiency Preceding Splenic Marginal Zone Lymphoma: Further Insights from Clinical Practice.获得性血管性水肿伴 C1 抑制剂缺乏继发脾边缘区淋巴瘤:来自临床实践的进一步见解。
Int Arch Allergy Immunol. 2020;181(12):941-946. doi: 10.1159/000509805. Epub 2020 Sep 7.
6
Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients.无风团性血管性水肿的表现、诊断和治疗:1058 例患者队列的回顾性分析。
J Intern Med. 2015 May;277(5):585-93. doi: 10.1111/joim.12304. Epub 2014 Sep 27.
7
Acquired Angioedema due to C1-Inhibitor Deficiency: A Challenging Condition.C1抑制剂缺乏所致获得性血管性水肿:一种具有挑战性的病症。
Int Arch Allergy Immunol. 2022;183(5):572-577. doi: 10.1159/000521646. Epub 2022 Mar 24.
8
Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.缓激肽介导的血管性水肿的诊断与治疗:血管性水肿专家共识会议的结果
Int Arch Allergy Immunol. 2014;165(2):119-27. doi: 10.1159/000368404. Epub 2014 Nov 15.
9
Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic Patients.获得性血管性水肿伴 C1 抑制剂缺乏症:发生情况、临床特征和治疗:捷克共和国患者的全国回顾性研究。
Int Arch Allergy Immunol. 2021;182(7):642-649. doi: 10.1159/000512933. Epub 2021 Jan 20.
10
Chapter 22: Hereditary and acquired angioedema.第二十二章:遗传性和获得性血管性水肿。
Allergy Asthma Proc. 2012 May-Jun;33 Suppl 1:73-76. doi: 10.2500/aap.2012.33.3555.

引用本文的文献

1
Expanding the Genetic and Clinical Spectrum of Hereditary Angioedema with Normal C1 Inhibitor: Novel Variants and Treatment Insights.扩大C1抑制剂正常的遗传性血管性水肿的遗传和临床谱:新变异及治疗见解
J Clin Immunol. 2025 Aug 23;45(1):124. doi: 10.1007/s10875-025-01912-z.

本文引用的文献

1
Angioedema as a Rare Presentation of Systemic Lupus Erythematosus.血管性水肿作为系统性红斑狼疮的一种罕见表现
Cureus. 2022 Nov 21;14(11):e31763. doi: 10.7759/cureus.31763. eCollection 2022 Nov.
2
Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review.获得性血管性水肿(C1 抑制剂缺乏症)的研究现状:系统文献回顾。
Clin Immunol. 2021 Sep;230:108819. doi: 10.1016/j.clim.2021.108819. Epub 2021 Aug 4.
3
Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene.
纤溶酶原基因 c.988A>G(p.Lys330Glu)变异患者的遗传性血管性水肿治疗。
Orphanet J Rare Dis. 2020 Feb 17;15(1):52. doi: 10.1186/s13023-020-1334-8.
4
A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients.法国一项关于获得性C1抑制物缺乏症的全国性研究:92例患者的特征及治疗反应
Medicine (Baltimore). 2016 Aug;95(33):e4363. doi: 10.1097/MD.0000000000004363.
5
Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department.艾卡拉肽在急诊科治疗血管紧张素转换酶抑制剂所致血管性水肿的有效性
Ann Allergy Asthma Immunol. 2015 Mar;114(3):245-9. doi: 10.1016/j.anai.2014.12.007. Epub 2015 Jan 16.
6
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group.血管性水肿的分类、诊断和治疗方法:遗传性血管性水肿国际工作组的共识报告。
Allergy. 2014 May;69(5):602-16. doi: 10.1111/all.12380. Epub 2014 Mar 27.
7
Acquired angioedema--occurrence, clinical features and associated disorders in a Danish nationwide patient cohort.获得性血管性水肿——丹麦全国患者队列中的发生、临床特征和相关疾病。
Int Arch Allergy Immunol. 2013;162(2):149-55. doi: 10.1159/000351452. Epub 2013 Jul 31.
8
A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema.重点参数更新:遗传性血管性水肿、获得性 C1 抑制剂缺乏症和血管紧张素转换酶抑制剂相关性血管性水肿。
J Allergy Clin Immunol. 2013 Jun;131(6):1491-3. doi: 10.1016/j.jaci.2013.03.034.
9
Raising awareness of orolingual angioedema as a complication of thrombolysis in acute stroke patients.提高对急性卒中患者溶栓并发症口咽血管性水肿的认识。
Cerebrovasc Dis. 2009;27(3):307-8. doi: 10.1159/000201558. Epub 2009 Feb 11.
10
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management.获得性第一补体成分抑制物缺乏症:临床表现、诊断、病程及传统治疗
Immunol Allergy Clin North Am. 2006 Nov;26(4):669-90. doi: 10.1016/j.iac.2006.08.002.